Medical - Pharmaceuticals
The companies in this industry manufacture and process pharmaceutical products in the treatment of health disorders and illnesses. Demand for pharmaceuticals is driven by the desire to cure illness and disease. The profitability of individual companies depends on their ability to discover and market new drugs.
Share This Page
Industry Rating
Loading, please wait...
Rk | Symbol | Name | Last | Day
Chg
| Mkt
Cap
| POWR
|
---|---|---|---|---|---|---|
1 | NVS | Novartis AG ADR | 102.87 | -2.98 (-2.82%) | 210.27B | A |
2 | RHHBY | Roche Holding AG ADR | 36.00 | -1.65 (-4.38%) | 229.61B | A |
3 | ESAIY | Eisai Co. Ltd. ADR | 6.24 | -0.24 (-3.70%) | N/A | A |
4 | TARO | Taro Pharmaceutical Industries Ltd. | 42.97 | 0.00 (0.00%) | 1.62B | NR |
5 | AZN | AstraZeneca PLC ADR | 65.79 | -2.67 (-3.90%) | 204.03B | A |
6 | MRK | Merck & Co. Inc. | 81.18 | -0.29 (-0.36%) | 205.06B | A |
7 | SNPHY | SANTEN PHARMACEUTICAL CO., LTD. | 9.81 | 0.30 (3.10%) | N/A | A |
8 | JNJ | Johnson & Johnson | 150.62 | -2.62 (-1.71%) | 362.97B | A |
9 | BMY | Bristol-Myers Squibb Co. | 55.19 | -0.11 (-0.20%) | 112.30B | A |
10 | HZNP | Horizon Therapeutics PLC | 116.30 | 0.05 (0.04%) | 26.63B | NR |
11 | AUPH | Aurinia Pharmaceuticals Inc | 7.59 | -0.22 (-2.82%) | 1.04B | A |
12 | GSK | GSK PLC ADR | 34.84 | -1.69 (-4.63%) | 72.11B | A |
13 | ABBV | AbbVie Inc. | 186.55 | -0.41 (-0.22%) | 330.00B | A |
14 | CPRX | Catalyst Pharmaceuticals, Inc. | 21.81 | -1.26 (-5.46%) | 2.65B | A |
15 | CALT | Calliditas Therapeutics AB ADR | 40.00 | -0.16 (-0.40%) | 1.19B | A |
16 | NVO | Novo Nordisk A/S ADR | 63.64 | 1.09 (1.74%) | 285.59B | A |
17 | ALPMY | Astellas Pharma Inc. ADR | 8.86 | -0.33 (-3.59%) | 16.03B | A |
18 | SUPN | Supernus Pharmaceuticals, Inc. | 32.27 | -0.47 (-1.44%) | 1.80B | B |
19 | KMDA | Kamada Ltd. | 5.84 | -0.15 (-2.50%) | 335.68M | B |
20 | NBIX | Neurocrine Biosciences, Inc. | 93.25 | -2.40 (-2.51%) | 9.30B | B |
21 | SNY | Sanofi - ADR | 50.76 | -1.22 (-2.35%) | 128.23B | B |
22 | PCRX | Pacira BioSciences, Inc. | 22.91 | -0.19 (-0.82%) | 1.06B | B |
23 | BTMD | Biote Corp. | 3.25 | -0.04 (-1.22%) | 177.81M | B |
24 | AMRX | Amneal Pharmaceuticals, Inc. | 7.21 | -0.17 (-2.30%) | 2.23B | B |
25 | RIGL | Rigel Pharmaceuticals, Inc. | 17.04 | -0.20 (-1.16%) | 304.39M | B |
26 | DSNKY | Daiichi Sankyo Company, Limited | 23.90 | -0.10 (-0.42%) | 45.61B | B |
27 | PFE | Pfizer Inc. | 22.63 | -0.34 (-1.48%) | 128.35B | B |
28 | HLUYY | H. Lundbeck A/S | 22.00 | -0.01 (-0.02%) | 21.91B | NR |
29 | COLL | Collegium Pharmaceutical, Inc. | 27.38 | -0.76 (-2.70%) | 879.77M | B |
30 | CPIX | Cumberland Pharmaceuticals Inc. | 4.11 | -0.12 (-2.84%) | 57.41M | B |
31 | PROC | Procaps Group, S.A. | 1.01 | -0.58 (-36.51%) | 113.95M | B |
32 | LLY | Eli Lilly & Co. | 723.73 | -14.48 (-1.96%) | 686.22B | B |
33 | HLN | Haleon PLC ADR | 9.27 | -0.62 (-6.27%) | 41.88B | B |
34 | GDRX | GoodRx Holdings, Inc. | 4.01 | -0.11 (-2.67%) | 1.54B | B |
35 | CRLBF | Cresco Labs Inc. | 0.56 | -0.03 (-5.49%) | 273.36M | B |
36 | MEIP | MEI Pharma, Inc. | 1.93 | -0.07 (-3.50%) | 12.86M | B |
37 | SNOA | Sonoma Pharmaceuticals, Inc. | 1.91 | -0.11 (-5.45%) | 3.09M | B |
38 | KPRX | Kiora Pharmaceuticals Inc. | 2.60 | -0.03 (-1.14%) | 7.80M | B |
39 | PSTX | Poseida Therapeutics Inc. | 9.50 | -0.06 (-0.63%) | 928.85M | B |
40 | OPHLY | ONO PHARMACEUTICAL CO., LTD. | 3.71 | 0.15 (4.21%) | N/A | B |
41 | ACAD | ACADIA Pharmaceuticals Inc. | 14.61 | -0.77 (-5.01%) | 2.44B | B |
42 | JUSHF | Jushi Holdings Inc. | 0.26 | -0.01 (-2.92%) | 50.38M | B |
43 | BHC | Bausch Health Companies Inc. | 5.26 | -0.07 (-1.31%) | 1.94B | B |
44 | XERS | Xeris Pharmaceuticals, Inc. | 4.41 | 0.00 (0.00%) | 678.88M | B |
45 | IRWD | Ironwood Pharmaceuticals, Inc. - | 1.27 | -0.07 (-5.22%) | 205.50M | B |
46 | IPSEY | Ipsen S.A. | 26.46 | -1.89 (-6.68%) | 8.87B | B |
47 | KNSA | Kiniksa Pharmaceuticals, Ltd. - | 20.28 | -0.08 (-0.39%) | 1.47B | B |
48 | ZTS | Zoetis Inc. | 149.10 | -2.63 (-1.73%) | 66.77B | B |
49 | ACIU | AC Immune SA | 1.59 | -0.07 (-4.22%) | 159.65M | B |
50 | FENC | Fennec Pharmaceuticals Inc. | 5.21 | -0.04 (-0.76%) | 143.73M | B |
51 | TEVA | Teva Pharmaceutical Industries Ltd. ADR | 13.94 | 0.14 (1.01%) | 15.81B | B |
52 | WXXWY | WuXi Biologics (Cayman) Inc. | 4.70 | -1.06 (-18.40%) | N/A | B |
53 | CLLS | Cellectis S.A. | 1.16 | 0.01 (0.87%) | 64.48M | B |
54 | ESALY | Eisai Co. Ltd. ADR | 61.51 | -1.33 (-2.11%) | 17.64B | NR |
55 | BAYRY | Bayer AG ADR | 5.45 | -0.05 (-0.91%) | 21.42B | C |
56 | AERI | Aerie Pharmaceuticals, Inc. | 15.25 | 0.01 (0.07%) | 753.61M | NR |
57 | GTBIF | Green Thumb Industries Inc. | 5.06 | 0.04 (0.80%) | 1.07B | C |
58 | TAK | Takeda Pharmaceutical Co. Ltd. ADR | 14.38 | -0.34 (-2.31%) | 45.76B | C |
59 | ASRT | Assertio Therapeutics, Inc. | 0.59 | -0.04 (-5.93%) | 56.51M | C |
60 | PRGO | Perrigo Co. PLC | 26.04 | -0.27 (-1.03%) | 3.55B | C |
61 | ELAN | Elanco Animal Health Incorporated | 8.94 | -0.21 (-2.30%) | 4.44B | C |
62 | EOLS | Evolus, Inc. | 10.24 | -0.45 (-4.21%) | 651.13M | C |
63 | GBIO | Generation Bio Inc. | 0.38 | 0.00 (0.78%) | 25.15M | C |
64 | TCNNF | Trulieve Cannabis Corp. | 3.30 | 0.07 (2.17%) | N/A | C |
65 | CTMX | CytomX Therapeutics, Inc. | 0.43 | -0.02 (-5.29%) | 34.56M | C |
66 | GRFS | Grifols, S.A. | 6.55 | -0.10 (-1.50%) | 4.50B | C |
67 | WVE | Wave Life Sciences Ltd. - Ordinary Shares | 5.80 | -0.23 (-3.81%) | 890.22M | C |
68 | SLGL | Sol-Gel Technologies Ltd. | 0.47 | 0.00 (0.95%) | 13.09M | NR |
69 | RDY | Dr. Reddy's Laboratories Ltd | 12.58 | 0.22 (1.78%) | 10.50B | C |
70 | VTRS | Viatris Inc. | 7.61 | -0.01 (-0.13%) | 9.08B | C |
71 | ENDP | Endo International PLC | 0.29 | -0.02 (-5.00%) | 68.80M | NR |
72 | EGRX | Eagle Pharmaceuticals, Inc. | 1.85 | -0.04 (-1.86%) | 24.03M | C |
73 | ADMS | Adamas Pharmaceuticals, Inc. | 8.22 | 0.06 (0.74%) | 376.37M | NR |
74 | ARVN | Arvinas, Inc. | 6.37 | -0.19 (-2.90%) | 438.08M | C |
75 | CUE | Cue Biopharma, Inc. | 0.63 | -0.05 (-7.30%) | 38.69M | C |
76 | ASMB | Assembly Biosciences, Inc. | 8.63 | -0.08 (-0.92%) | 64.75M | C |
77 | AVDL | Avadel Pharmaceuticals plc each representing one Ordinary Share | 6.69 | -0.11 (-1.62%) | 646.45M | C |
78 | APLS | Apellis Pharmaceuticals, Inc. | 19.80 | -0.17 (-0.85%) | 2.49B | C |
79 | AXSM | Axsome Therapeutics, Inc. | 98.50 | -0.36 (-0.36%) | 4.80B | C |
80 | PTGX | Protagonist Therapeutics, Inc. | 43.21 | -1.23 (-2.77%) | 2.65B | C |
81 | EVTCY | Evotec SE | 22.96 | -0.01 (-0.04%) | 7.58B | NR |
82 | HYPMY | Hypera S.A. | 3.42 | -0.17 (-4.74%) | 2.17B | C |
83 | SURF | Surface Oncology, Inc. | 1.07 | -0.01 (-0.93%) | 65.08M | NR |
84 | OGN | Organon & Co. | 12.52 | -0.53 (-4.06%) | 3.23B | C |
85 | MGTA | Magenta Therapeutics, Inc. | 0.70 | -0.06 (-7.74%) | 42.44M | NR |
86 | CCHWF | Columbia Care Inc. | 0.94 | -0.20 (-17.25%) | N/A | NR |
87 | PTPI | Petros Pharmaceuticals Inc. | 0.06 | -0.00 (-6.12%) | 3.37M | C |
88 | CWBHF | Charlotte's Web Holdings, Inc. | 0.08 | 0.00 (1.25%) | N/A | NR |
89 | MTEM | Molecular Templates, Inc. | 0.00 | 0.00 (0.00%) | 0.66K | NR |
90 | IMAB | I-Mab ADR | 0.62 | -0.06 (-8.82%) | 50.53M | C |
91 | KPTI | Karyopharm Therapeutics Inc. | 4.04 | 0.18 (4.66%) | 34.00M | C |
92 | LPCN | Lipocine Inc. | 2.84 | -0.17 (-5.65%) | 15.19M | C |
93 | OSMT | Osmotica Pharmaceuticals plc - Ordinary Shares | 1.11 | -0.02 (-1.77%) | 69.47M | NR |
94 | LZAGY | Lonza Group AG ADR | 57.21 | -1.65 (-2.80%) | 41.32B | C |
95 | SMTI | Sanara MedTech Inc. | 27.55 | -0.24 (-0.86%) | 245.25M | C |
96 | HOOK | HOOKIPA Pharma Inc. | 0.82 | -0.01 (-0.61%) | 9.89M | C |
97 | AMPH | Amphastar Pharmaceuticals, Inc. | 25.00 | -1.61 (-6.05%) | 1.19B | C |
98 | BFRA | Biofrontera AG | 2.67 | -0.28 (-9.49%) | 75.72M | NR |
99 | ALIM | Alimera Sciences, Inc. | 5.54 | -0.01 (-0.18%) | 290.24M | C |
100 | OPTN | OptiNose, Inc. | 9.10 | 0.00 (0.00%) | 91.66M | C |
101 | STRO | Sutro Biopharma, Inc. | 0.72 | 0.18 (32.82%) | 59.37M | C |
102 | VRNOF | Verano Holdings Corp. | 0.53 | -0.01 (-1.39%) | 191.14M | C |
103 | GRVI | GROVE, INC. | 4.95 | 0.35 (7.61%) | 83.26M | NR |
104 | SYBX | Synlogic, Inc. | 1.08 | 0.00 (0.00%) | 12.63M | C |
105 | ELOX | Eloxx Pharmaceuticals, Inc. | 0.00 | 0.00 (0.00%) | 0.31K | NR |
106 | NEOS | Neos Therapeutics, Inc. | 1.15 | -0.03 (-2.54%) | 57.22M | NR |
107 | SPRO | Spero Therapeutics, Inc. | 0.60 | 0.02 (3.06%) | 33.53M | C |
108 | TXMD | TherapeuticsMD, Inc. | 0.90 | 0.02 (2.24%) | 10.46M | NR |
109 | VRCA | Verrica Pharmaceuticals Inc. | 0.65 | 0.12 (21.75%) | 59.23M | C |
110 | RDHL | Redhill Biopharma Ltd. | 2.05 | 0.10 (5.13%) | 2.63M | C |
111 | BVXV | BiondVax Pharmaceuticals Ltd. | 1.36 | 0.05 (3.82%) | 2.54M | NR |
112 | APNHY | Aspen Pharmacare Holdings Limited | 7.48 | -0.22 (-2.86%) | 3.34B | C |
113 | TCDA | Tricida, Inc. | 0.11 | -0.01 (-10.00%) | 6.01M | NR |
114 | ETON | Eton Pharmaceuticals, Inc. | 11.85 | 0.02 (0.17%) | 317.79M | C |
115 | HAPP | HAPPINESS BIOTECH GROUP LTD | 4.50 | 0.06 (1.35%) | 31.30M | NR |
116 | BFRI | Biofrontera Inc. | 0.72 | -0.02 (-2.70%) | 6.39M | C |
117 | MGTX | MeiraGTx Holdings plc - Ordinary Shares | 5.75 | 0.07 (1.23%) | 453.42M | C |
118 | MTCR | Metacrine Inc. | 0.58 | -0.01 (-1.29%) | 24.75M | NR |
119 | RMTI | Rockwell Medical, Inc. | 0.97 | -0.03 (-2.90%) | 33.07M | C |
120 | ARCT | Arcturus Therapeutics Holdings Inc. | 9.09 | -0.02 (-0.27%) | 246.52M | C |
121 | MYOV | Myovant Sciences Ltd. Common Shares | 26.98 | -0.01 (-0.04%) | 2.62B | NR |
122 | IVA | Inventiva S.A. ADR | 3.10 | 0.03 (1.14%) | 162.68M | C |
123 | ABEO | Abeona Therapeutics Inc. | 4.51 | -0.01 (-0.33%) | 218.89M | C |
124 | PYPD | PolyPid Ltd. | 2.40 | -0.11 (-4.38%) | 24.46M | NR |
125 | ZGNX | Zogenix, Inc. | 26.68 | 0.42 (1.60%) | 1.50B | NR |
126 | ORTX | Orchard Therapeutics plc | 16.70 | 0.05 (0.30%) | 380.11M | NR |
127 | CNTA | Centessa Pharmaceuticals Limited | 11.28 | -0.40 (-3.42%) | 1.50B | C |
128 | ERYP | Erytech Pharma S.A. | 0.78 | 0.00 (0.00%) | 26.61M | NR |
129 | ACB | Aurora Cannabis Inc. | 4.05 | 0.04 (0.87%) | 227.67M | C |
130 | ECOR | electroCore, Inc. | 5.68 | 0.02 (0.35%) | 40.86M | C |
131 | SBBP | Strongbridge Biopharma plc - Ordinary Shares | 2.00 | 0.03 (1.52%) | 135.66M | NR |
132 | HROW | Harrow Health, Inc. | 23.09 | -0.43 (-1.83%) | 823.25M | C |
133 | NBRV | Nabriva Therapeutics plc - Ordinary Shares | 1.42 | 0.00 (0.00%) | 45.46M | NR |
134 | IMCC | IM Cannabis Corp. | 1.31 | -0.06 (-4.38%) | 2.92M | C |
135 | VYGR | Voyager Therapeutics, Inc. | 3.06 | -0.03 (-0.97%) | 168.93M | C |
136 | ODT | Odonate Therapeutics, Inc. | 1.12 | -0.05 (-4.27%) | 43.11M | NR |
137 | SNDL | Sundial Growers Inc. | 1.33 | -0.04 (-2.92%) | 349.49M | C |
138 | LCI | Lannett Co Inc | 0.69 | 0.03 (3.86%) | 7.38M | NR |
139 | UROV | Urovant Sciences Ltd. | 16.24 | 0.01 (0.06%) | 531.75M | NR |
140 | AYRWF | Ayr Strategies Inc. | 0.13 | 0.00 (1.15%) | 15.28M | C |
141 | PRLD | Prelude Therapeutics Inc. | 0.65 | -0.03 (-3.99%) | 35.75M | C |
142 | TKNO | Alpha Teknova, Inc. | 4.51 | -0.17 (-3.63%) | 241.00M | C |
143 | ITRM | Iterum Therapeutics plc - Ordinary Share | 1.11 | -0.02 (-1.77%) | 38.38M | C |
144 | SMMT | Summit Therapeutics plc | 17.32 | -0.04 (-0.23%) | 12.78B | C |
145 | RPTX | Repare Therapeutics Inc. | 0.96 | -0.04 (-4.02%) | 40.80M | C |
146 | CURLF | Curaleaf Holdings, Inc. | 0.74 | -0.03 (-4.23%) | 488.09M | C |
147 | YCBD | cbdMD Inc. | 0.23 | -0.00 (-1.41%) | 1.44M | C |
148 | FLXN | Flexion Therapeutics, Inc. | 9.12 | -0.02 (-0.22%) | 458.93M | NR |
149 | CRXT | Clarus Therapeutics Holdings, Inc. | 0.05 | -0.02 (-31.16%) | 2.47M | NR |
150 | MOR | MorphoSys AG | 18.96 | 0.45 (2.43%) | 2.86B | C |
151 | CVSI | CV Sciences, Inc. | 0.03 | -0.00 (-0.66%) | 5.54M | NR |
152 | CTLT | Catalent Inc. | 63.48 | 0.00 (0.00%) | 11.52B | C |
153 | BYSI | BeyondSpring, Inc. - Ordinary Shares | 1.15 | -0.19 (-14.18%) | 46.36M | C |
154 | HUGE | FSD Pharma Inc. | 0.09 | -0.01 (-10.10%) | 3.61M | NR |
155 | LHSIF | Liberty Health Sciences Inc. | 1.14 | -0.03 (-2.17%) | 392.01M | NR |
156 | MIRM | Mirum Pharmaceuticals, Inc. - common stock | 41.00 | -1.03 (-2.45%) | 2.01B | D |
157 | NVCR | Novocure Ltd. | 16.61 | 0.12 (0.73%) | 1.83B | D |
158 | RYTM | Rhythm Pharmaceuticals, Inc. | 54.96 | 8.01 (17.06%) | 3.47B | D |
159 | FIXX | Homology Medicines, Inc. | 0.93 | 0.01 (0.77%) | 54.34M | D |
160 | YMAB | Y-mAbs Therapeutics, Inc. | 4.28 | -0.26 (-5.73%) | 193.53M | D |
161 | FFNTF | 4Front Ventures Corp. | 0.01 | -0.00 (-13.73%) | N/A | NR |
162 | VBLT | Vascular Biogenics Ltd. - Ordinary Shares | 0.16 | -0.02 (-8.77%) | 12.11M | NR |
163 | LSDI | Lucy Scientific Discovery Inc. | 0.51 | -0.16 (-23.29%) | 907.03K | NR |
164 | MIST | Milestone Pharmaceuticals Inc. | 0.68 | -0.02 (-2.26%) | 36.28M | D |
165 | ETTX | Entasis Therapeutics Holdings Inc. | 2.19 | -0.01 (-0.45%) | 104.80M | NR |
166 | SYRS | Syros Pharmaceuticals, Inc. - common stock | 0.03 | 0.01 (21.01%) | 772.76K | D |
167 | SBFM | Sunshine Biopharma Inc. | 1.49 | -0.08 (-5.10%) | 1.82M | D |
168 | MDGL | Madrigal Pharmaceuticals, Inc. | 310.52 | -3.87 (-1.23%) | 6.86B | D |
169 | TRSSF | TerrAscend Corp. | 1.72 | 0.00 (0.00%) | 433.20M | NR |
170 | RLAY | Relay Therapeutics Inc. | 2.05 | 0.05 (2.50%) | 347.52M | D |
171 | CHMA | Chiasma, Inc. | 3.76 | -0.24 (-6.00%) | 217.68M | NR |
172 | CLSD | Clearside Biomedical, Inc. | 0.85 | -0.02 (-1.82%) | 65.21M | D |
173 | ATNX | Athenex, Inc. | 0.20 | -0.06 (-23.39%) | 1.76M | NR |
174 | APTX | Aptinyx Inc. | 0.10 | 0.00 (3.11%) | 6.50M | NR |
175 | SLRX | Salarius Pharmaceuticals Inc | 0.72 | 0.01 (1.22%) | 1.24M | D |
176 | BTAI | BioXcel Therapeutics, Inc. | 1.56 | -0.07 (-4.29%) | 8.56M | D |
177 | NOVN | Novan, Inc. | 0.09 | -0.03 (-24.84%) | 2.64M | NR |
178 | TERN | Terns Pharmaceuticals, Inc. | 2.00 | -0.10 (-4.76%) | 174.60M | D |
179 | SXTC | China SXT Pharmaceuticals, Inc. | 2.61 | 0.16 (6.53%) | 1.89M | D |
180 | TRVI | Trevi Therapeutics, Inc. | 5.78 | -0.27 (-4.46%) | 558.82M | D |
181 | ACRHF | Acreage Holdings, Inc. | 0.00 | -0.00 (-2.44%) | N/A | NR |
182 | MMNFF | MedMen Enterprises Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
183 | OPNT | Opiant Pharmaceuticals, Inc. | 20.65 | -0.12 (-0.58%) | 106.64M | NR |
184 | ALXO | ALX Oncology Holdings Inc. | 0.54 | 0.02 (3.76%) | 28.58M | D |
185 | MLYS | Mineralys Therapeutics Inc. | 12.05 | -0.35 (-2.82%) | 756.56M | D |
186 | KALV | KalVista Pharmaceuticals, Inc. | 11.50 | 0.79 (7.38%) | 571.73M | D |
187 | TYME | Tyme Technologies, Inc. | 0.31 | 0.02 (8.07%) | 53.50M | NR |
188 | PHAS | PhaseBio Pharmaceuticals, Inc. | 0.07 | -0.02 (-26.21%) | 3.50M | NR |
189 | NTEC | Intec Pharma Ltd. - Ordinary Shares | 9.63 | -1.37 (-12.48%) | 8.65M | NR |
190 | VTVT | vTv Therapeutics Inc. - | 15.35 | -0.91 (-5.60%) | 48.97M | D |
191 | MESO | Mesoblast Limited | 10.40 | -0.17 (-1.61%) | 1.32B | D |
192 | RDUS | Radius Health, Inc. | 28.71 | -0.23 (-0.79%) | 808.33M | D |
193 | AGRX | Agile Therapeutics, Inc. | 1.51 | 0.00 (0.00%) | 10.35M | D |
194 | HRVSF | Harvest Health & Recreation Inc. | 3.22 | 0.03 (0.94%) | N/A | NR |
195 | APM | Aptorum Group Limited - Class A Ordinary Shares | 0.71 | -0.04 (-5.35%) | 3.68M | D |
196 | EPIX | ESSA Pharma Inc. | 1.44 | -0.04 (-2.70%) | 63.92M | D |
197 | ALLO | Allogene Therapeutics, Inc. | 1.43 | -0.01 (-0.69%) | 310.69M | D |
198 | SCYX | SCYNEXIS, Inc. | 0.81 | -0.03 (-3.74%) | 31.52M | D |
199 | EVOK | Evoke Pharma, Inc. | 2.35 | 0.10 (4.44%) | 3.51M | NR |
200 | TENX | Tenax Therapeutics, Inc. | 5.75 | -0.05 (-0.86%) | 22.83M | D |
201 | NVCT | Nuvectis Pharma Inc. | 8.24 | -0.01 (-0.12%) | 192.75M | D |
202 | DNLI | Denali Therapeutics Inc. | 11.60 | -0.18 (-1.53%) | 1.68B | D |
203 | DRRX | DURECT Corporation | 0.80 | 0.02 (2.18%) | 24.83M | D |
204 | BBIO | BridgeBio Pharma, Inc. | 30.67 | -0.70 (-2.23%) | 5.83B | D |
205 | NTRB | Nutriband Inc. | 5.09 | -0.31 (-5.74%) | 56.53M | D |
206 | HEXO | HEXO Corp. | 0.71 | 0.02 (2.45%) | 31.24M | NR |
207 | KALA | Kala Pharmaceuticals, Inc. | 3.74 | -0.50 (-11.79%) | 24.13M | D |
208 | VERU | Veru Inc. | 0.57 | 0.00 (0.02%) | 83.42M | D |
209 | NYMX | Nymox Pharmaceutical Corporation | 0.20 | -0.05 (-19.68%) | 18.10M | NR |
210 | BKUH | Bakhu Holdings, Corp. | 0.02 | -0.49 (-97.00%) | N/A | NR |
211 | ITOS | iTeos Therapeutics Inc. | 5.25 | -0.14 (-2.60%) | 200.52M | D |
212 | RCEL | AVITA Medical, Inc. | 7.76 | 0.26 (3.47%) | 203.45M | D |
213 | GLSI | Greenwich LifeSciences Inc. | 9.59 | 0.76 (8.61%) | 126.06M | D |
214 | SCPH | scPharmaceuticals Inc. | 2.33 | 0.01 (0.43%) | 117.16M | D |
215 | GRAL | GRAIL Inc. | 23.98 | 1.73 (7.78%) | 812.80M | D |
216 | CMPI | Checkmate Pharmaceuticals Inc. | 10.50 | 0.02 (0.19%) | 231.40M | NR |
217 | ACRX | AcelRx Pharmaceuticals, Inc. | 0.86 | 0.06 (7.50%) | 14.58M | NR |
218 | OGI | OrganiGram Holdings Inc. | 0.92 | -0.03 (-3.22%) | 116.16M | D |
219 | CLDI | Calidi Biotherapeutics Inc. | 0.50 | 0.00 (0.00%) | 13.13M | D |
220 | CRNX | Crinetics Pharmaceuticals, Inc. | 26.38 | -0.51 (-1.90%) | 2.45B | D |
221 | SVRA | Savara, Inc. | 2.75 | -0.10 (-3.51%) | 474.74M | D |
222 | ALBO | Albireo Pharma, Inc. | 44.15 | -0.10 (-0.23%) | 913.95M | NR |
223 | RGC | Regencell Bioscience Holdings Ltd. | 28.93 | -3.28 (-10.18%) | 376.47M | D |
224 | APLT | Applied Therapeutics, Inc. | 0.41 | -0.02 (-5.73%) | 47.71M | D |
225 | FUSN | Fusion Pharmaceuticals Inc. | 21.55 | 0.03 (0.14%) | 1.83B | D |
226 | REPL | Replimune Group, Inc. | 7.49 | 0.03 (0.40%) | 576.84M | D |
227 | ALNA | Allena Pharmaceuticals, Inc. | 0.08 | 0.00 (3.16%) | 9.16M | NR |
228 | GRAY | Graybug Vision Inc | 5.50 | -0.67 (-10.80%) | 8.64M | NR |
229 | ACRS | Aclaris Therapeutics, Inc. | 1.33 | -0.07 (-5.00%) | 143.53M | D |
230 | ARDS | Aridis Pharmaceuticals Inc. | 0.00 | 0.00 (0.00%) | 5.33K | NR |
231 | LYRA | Lyra Therapeutics Inc. | 0.11 | -0.01 (-7.21%) | 7.37M | D |
232 | ACER | Acer Therapeutics Inc. | 0.66 | -0.14 (-17.95%) | 16.15M | NR |
233 | RETA | Reata Pharmaceuticals, Inc. - | 172.36 | 0.04 (0.02%) | 6.58B | NR |
234 | ORGS | Orgenesis Inc. | 2.20 | -0.32 (-12.80%) | 10.55M | D |
235 | IMRN | Immuron Limited | 1.73 | -0.05 (-2.81%) | 10.10M | NR |
236 | ZYNE | Zynerba Pharmaceuticals, Inc. | 1.30 | 0.03 (2.36%) | 70.12M | NR |
237 | SNES | SenesTech, Inc. | 1.37 | -0.10 (-6.81%) | 2.39M | D |
238 | CMPS | COMPASS Pathways PLC ADR | 2.70 | -0.01 (-0.37%) | 250.22M | D |
239 | JUVAF | Juva Life Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
240 | LQDA | Liquidia Technologies, Inc. | 12.43 | -0.47 (-3.64%) | 1.06B | D |
241 | CNSP | CNS PHARMACEUTICALS, INC. | 1.12 | 0.02 (1.82%) | 3.30M | D |
242 | ATXI | Avenue Therapeutics, Inc. | 0.26 | -0.01 (-2.00%) | 523.77K | D |
243 | ADIL | Adial Pharmaceuticals, Inc | 0.72 | 0.09 (13.73%) | 4.73M | D |
244 | GPCR | Structure Therapeutics Inc. ADR | 14.31 | -0.81 (-5.36%) | 820.58M | D |
245 | IONS | Ionis Pharmaceuticals, Inc. | 27.57 | 0.48 (1.77%) | 4.38B | D |
246 | CKPT | Checkpoint Therapeutics, Inc. | 3.99 | -0.02 (-0.50%) | 334.22M | D |
247 | EYPT | EyePoint Pharmaceuticals, Inc. | 4.62 | 0.01 (0.22%) | 317.53M | D |
248 | HOTH | Hoth Therapeutics, Inc. | 0.79 | -0.05 (-5.94%) | 10.41M | D |
249 | SNGX | Soligenix, Inc. | 1.87 | 0.03 (1.63%) | 4.69M | D |
250 | TLRY | Tilray Brands Inc. Cl 2 | 0.58 | -0.01 (-2.18%) | 543.18M | D |
251 | PCVX | Vaxcyte Inc. | 32.51 | 0.91 (2.88%) | 4.19B | D |
252 | SNDX | Syndax Pharmaceuticals, Inc. | 11.01 | -0.24 (-2.13%) | 947.34M | D |
253 | VREOF | Vireo Health International, Inc. | 0.38 | -0.05 (-11.15%) | N/A | NR |
254 | IDYA | IDEAYA Biosciences, Inc. | 15.14 | 0.43 (2.92%) | 1.33B | F |
255 | RFL | Rafael Holdings, Inc. Class B | 1.75 | 0.03 (1.74%) | 43.60M | NR |
256 | ANVS | Annovis Bio Inc. | 1.24 | -0.07 (-5.34%) | 17.65M | F |
257 | CNST | Constellation Pharmaceuticals, Inc. | 33.99 | 0.02 (0.06%) | 1.63B | NR |
258 | BGXX | Bright Green Corp. | 0.04 | -0.00 (-2.56%) | 7.26M | NR |
259 | CGC | Canopy Growth Corporation | 0.93 | 0.01 (1.09%) | 147.51M | F |
260 | ACST | Acasti Pharma, Inc. - | 3.37 | -0.03 (-0.88%) | 31.67M | NR |
261 | ZOM | Zomedica Corp. | 0.10 | -0.00 (-0.21%) | 95.35M | NR |
262 | CDMO | Avid Bioservices, Inc. | 12.49 | 0.01 (0.08%) | 798.90M | F |
263 | VKTX | Viking Therapeutics, Inc. | 21.28 | -1.34 (-5.92%) | 2.39B | F |
264 | NNOX | Nano-X Imaging Ltd. | 4.41 | 0.01 (0.23%) | 254.81M | F |
265 | EYEN | Eyenovia, Inc. | 0.93 | -0.03 (-3.17%) | 1.30M | F |
266 | CDT | Conduit Pharmaceuticals Inc. | 0.65 | 0.00 (0.67%) | 4.33M | F |
267 | PRFX | PainReform Ltd. | 1.92 | -0.17 (-8.13%) | 1.68M | F |
268 | RXRX | Recursion Pharmaceuticals Inc. | 4.20 | -0.04 (-0.94%) | 1.69B | F |
269 | SHOT | Safety Shot Inc. | 0.42 | 0.01 (1.47%) | 31.34M | F |
NR | CBDHF | HempFusion Wellness Inc. | 0.00 | 0.00 (900.00%) | N/A | NR |
NR | KHRNF | Khiron Life Sciences Corp. | 0.00 | 0.00 (0.00%) | N/A | NR |
NR | ANTCF | Aion Therapeutic Inc. | 0.01 | 0.00 (0.00%) | N/A | NR |
NR | MJNA | Medical Marijuana Inc. | 0.00 | 0.00 (0.00%) | N/A | NR |
NR | GDTC | CytoMed Therapeutics Ltd. | 2.38 | 0.00 (0.00%) | 26.04M | NR |
NR | ICNAF | Icanic Brands Company Inc. | 0.06 | 0.00 (0.00%) | N/A | NR |
NR | SLGWF | SLANG Worldwide Inc. | 0.00 | -0.00 (-24.39%) | N/A | NR |
NR | ACUR | Acura Pharmaceuticals | 0.02 | 0.00 (0.00%) | 1.32M | NR |
NR | TLC | Taiwan Liposome Company, Ltd. - ADRs | 7.00 | 0.00 (0.00%) | 294.54M | NR |
NR | ZEAL | Zealand Pharma A/S | 17.59 | 0.21 (1.21%) | 818.60M | NR |
NR | EIDX | Eidos Therapeutics, Inc. | 122.21 | -6.23 (-4.85%) | 4.75B | NR |
All price changes on this page include dividends and splits.